- Home
- / STipe Therapeutics
STipe Therapeutics
Total Funding
$21.9 M
STipe Therapeutics Summary
Company Summary
- Overview
- STipe Therapeutics is a biotechnology company that specializes in the immune-oncology field and therapies of interferon genes to target cancer. It develops and provides drugs for intracellular protein-protein interactions of the stimulator of interferon genes (STING) Pathway.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Aarhus, DK | view all locations
- Website
- http://stipetherapeutics.com
- Cybersecurity rating
Table of Contents
Key People
Martin Roelsgaard Jakobsen, Director
Christian Schetter, Chairman
Richard Bethell, Chief Development Officer
LocationsView all
1 location detected
Aarhus HQ
Denmark
Inge Lehmanns Gade 10
STipe Therapeutics Financials
Summary Financials
- Gross profit (FY, 2022)
- (€6.6M)
- Net income (FY, 2022)
- (€8.3M)
- Cash (FY, 2022)
- €5.3M
- EBIT (FY, 2022)
- (€8.8M)